All times are in the Central European Time Zone (CEST). If you need another time zone, this website might be useful to you: https://www.worldtimebuddy.com/
Download the Program Book for the European Meeting on HIV & Hepatitis 2022 here
Download the Abstract Book for the European Meeting on HIV & Hepatitis 2022 here
Founded twenty years ago as the European HIV Resistance Workshop, the European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance has evolved to embrace all aspects of the clinical care of people living with HIV in Europe. This workshop places emphasis in particular on optimal treatment strategies, clinical virology, molecular epidemiology, and public health aspects of HIV, HBV, HCV, as well as emerging viruses throughout Europe.
In the last decade, the meeting has been able to capture leading clinicians and researchers from different regions of Europe. As such, this meeting is the only European platform where HIV-treating physicians and clinical virologists get together on an annual basis to present their latest research results and discuss their clinical implications in detail.
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the meeting, identify interesting topics and candidate speakers, and review all submitted abstracts.
The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals, researchers, and community representatives involved in the development of treatment strategies and research of antiviral drug resistance in HIV, hepatitis, and emerging viruses.
This collaboration plays a vital role in both the organizational as well as the scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Jesper Niesen at Jesper.Niesen@amededu.com or call +31 30 2307 142.
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
*Subject to the support level
The 20th European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance Paris, France, 08/06/2022-10/06/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 15 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Ensuring the health and safety of our attendees, suppliers, and staff is our absolute number one priority. In order to provide a safe conference environment, all hybrid and live events organized by Virology Education will follow the national health and safety measures of the country where the meeting is being held in. We kindly ask that all attendees carefully abide by these measures to assist us in ensuring a safe environment for all.
The health and safety measures that will be taken by Virology Education during the European Meeting on HIV & Hepatitis are listed on the government website of France. In addition, you can find relevant hygiene protocols on the venue website. Please read them very carefully before travelling to the conference venue.
Our staff will be available onsite to address any questions or concerns that you might have. If you have any questions in advance, please contact the Conference Secretariat at paula.janiak@amededu.com.
Virology Education strongly advises participants to check the government website of France for the latest and most accurate information about the rules regarding travel.
Please be aware of measures such as testing requirements, vaccination requirements, whether your country of origin is mentioned on the Red List, etc.
What if I get ill during the event?
Should an attendee become ill or exhibit COVID-19 symptoms at any time during the event, the attendee will safely withdraw from the event venue and immediately notify the event organizer with details of other attendees which have been in close contact at the event. By registering for the event, the attendee declares, acknowledges, and accepts that they will comply with all local government requirements should they become ill or exhibit COVID-19 symptoms during the event.
Liability Waiver
Virology Education cannot guarantee that its participants, volunteers, partners, or others in attendance will not become infected with COVID-19.
To the maximum extent permitted by law, Virology Education accepts no liability for any illness, COVID-19 related or otherwise, that may subsequently be contracted after or during the event.
All participants acknowledge and agree that they are attending the event at their own risk.
Abstract submission is now closed
The registration fee is waived for early-career professionals and healthcare professionals from Low and Middle-Income Economies with an accepted abstract. A 50% discount is offered to early-career professionals and healthcare professionals from Low and Middle-Income Economies without an accepted abstract. The requirements for the application are specified below.
By submitting an abstract to a meeting organized by Virology Education BV (VE) or Academic Medical Education BV (AME), the abstract submitter hereby agrees to the terms and conditions.
The terms and conditions can be viewed here.
Management of the COVID-19 Pandemic in Europe | Diagnostics
by Ravindra Gupta, MD, PhD from University of Cambridge, United Kingdom
Hepatitis C Resistance: Pro-Con Debate
